In the ICGC cohort, KEGG pathways, such as “ribosome,” “cell cycle,” “complement and coagulation cascades,” “spliceosome,” and “RNA transport,” were most significantly enriched in HCC patients with higher C2 expression (all p < 0.001, Figure 5(c)). The gene discussed is C2; the disease is hepatocellular carcinoma.